New drug duo aims to control blood cancer in untreated patients
NCT ID NCT05718869
Summary
This study is testing whether combining two cancer drugs works better than either alone for people newly diagnosed with chronic lymphocytic leukemia (CLL) or small lymphocytic lymphoma (SLL). The trial will enroll 26 adults who have not yet received treatment for their cancer. Researchers will give participants both drugs to see if the combination is safe and can effectively kill cancer cells and lead to remission.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for CHRONIC LYMPHOCYTIC LEUKEMIA are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
City of Hope Medical Center
Duarte, California, 91010, United States
-
City of Hope at Irvine Lennar
Irvine, California, 92618, United States
-
University of Miami Sylvester Comprehensive Cancer Center
Miami, Florida, 33146, United States
Conditions
Explore the condition pages connected to this study.